Zulekha launches MICS bypass programme after 4 cases in Dubai and Sharjah

Zulekha Hospital has launched a Minimally Invasive Cardiac Surgery (MICS) programme after recording four successful MICS CABG procedures, according to a Gulf News report updated on 4 September 2026.

The immediate audience is hospital COOs, insurer contracting teams and medical directors. For Dubai and Sharjah providers, the launch adds another private-sector option for selected coronary artery bypass grafting patients who may be suitable for smaller incisions, early mobilisation and shorter recovery pathways. Dubai providers sit under the Dubai Health Authority (DHA). Sharjah and the northern emirates sit under the Ministry of Health and Prevention (MOHAP). Abu Dhabi and Al Ain providers should read the move through the Department of Health Abu Dhabi (DOH) lens, especially where patient referrals cross emirate lines.

What Zulekha says it has added

Gulf News reported that the programme is led by Dr. Pradheep K. Rachakonda, Consultant, Cardiothoracic and Minimal Access Heart Surgery. The report says the hospital has recorded four MICS CABG procedures in patients aged 42, 64, 65 and 68, all with significant blockages in multiple coronary arteries. The article gives named case summaries for three patients.

The operative distinction is access. Conventional bypass surgery usually opens the chest through the breastbone. In MICS CABG, the surgeon reaches the heart through smaller openings between the ribs, avoiding a full sternotomy in selected patients.

The operation we perform on the heart remains essentially the same. What changes is the route we use to get there. — Dr. Pradheep K. Rachakonda, Consultant, Cardiothoracic and Minimal Access Heart Surgery, Zulekha Hospital

The reported cases were clustered over 22 July to 7 August 2026. Mohammad Saleem, 65, underwent MICS CABG on 22 July 2026 and was discharged on 29 July. Patrick Dsouza, 68, underwent surgery on 24 July and was discharged on 31 July. Nabeel Nasir Kazi, 42, underwent minimally invasive bypass surgery on 7 August after admission with sudden chest pain and tests confirming a recent heart attack.

Why clinics and insurers should pay attention

For UAE clinics, the operational question is referral routing. A cardiology clinic without cardiac surgery must decide whether to send selected multivessel coronary artery disease patients to a centre offering MICS CABG, conventional CABG, percutaneous coronary intervention or medical therapy. That decision affects patient retention, diagnostic revenue and post-discharge rehabilitation flows.

For insurers, the issue is prior authorisation. Public UAE price lists for MICS CABG are not standardised by DHA, DOH or MOHAP. Contracted rates vary by hospital, network tier, surgeon, ICU use, implants, complications and length of stay. Finance teams should request case-level estimates before approval rather than rely on generic open-heart surgery bands. The minimum comparison should include:

• Surgeon, anaesthesia, theatre and perfusion fees.
• Expected ICU and ward days, with outlier rules.
• Consumables, imaging, blood products and rehabilitation.
• Readmission, wound complication and conversion-to-open-surgery clauses.

For patients, the eligibility filter matters more than the incision size. Gulf News reported that Zulekha assesses the heart condition, location and extent of blockages, physique, previous surgeries, overall health and procedure complexity before choosing MICS. That means clinics should avoid marketing MICS CABG as a default bypass route.

The UAE market implication

The launch places pressure on cardiac programmes in Dubai, Abu Dhabi and the northern emirates to publish clearer pathway data. Operators do not need broad claims. They need median length of stay, ICU days, conversion rate, reintervention rate, wound infection rate, return-to-work timing and 30-day readmission rate. Those figures can change payer confidence faster than a campaign around smaller scars.

Abu Dhabi providers working with Daman or Thiqa members, and Dubai or northern-emirates providers dealing with private payers such as Sukoon, should expect MICS requests to be reviewed against medical necessity and network contracts. Hospitals should have a one-page authorisation pack ready: angiography findings, surgical indication, why MICS is suitable, expected length of stay and the fallback plan if open conversion is needed.

Medical directors should focus on governance. A MICS CABG programme needs surgeon volume, cardiac anaesthesia, perfusion, ICU, physiotherapy and rehabilitation capacity. Gulf News said Zulekha supports the service with echocardiography, stress testing, cardiac catheterisation, coronary angiography and a Philips Azurion 7 C20 FlexArm imaging platform. Competitors should benchmark the whole pathway, rather than the operating room alone.

The next test is data. If Zulekha publishes 2026 outcomes for its first cohort, insurers and referring cardiologists will have a clearer basis for inclusion in cardiac pathways. Until then, UAE operators should treat MICS CABG as a selective capability with commercial consequences. Patients and clinics comparing licensed cardiology and cardiac surgery providers can start with the UAE Open Healthcare Directory.